newsfilter
← Latest News
GlobeNewswire·

Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026

  • Exagen Inc. (NASDAQ: XGN) will report Q1 2026 financial results before market open on May 11, 2026.
  • President & CEO John Aballi & CFO Jeff Black will host a conference call at 8:30 a.m. ET on May 11, 2026.
  • Call dial-in numbers are 877-407-0890 for the U.S. & +1 201-389-0918 internationally.
  • Live webcast & replay recordings will be available via investors.exagen.com.
  • Telephone replay access is available until May 25, 2026, using passcode 13759736.
  • Exagen specializes in autoimmune diagnostics, with its flagship product AVISE® CTD used for diagnosing lupus, rheumatoid arthritis, & Sjögren's disease.
  • The company operates a CLIA-certified, CAP-accredited laboratory in San Diego County, California.
  • Tina Jacobsen, CFA, serves as the investor relations contact at ir@exagen.com.